Clinical Study

Mild to moderate Alzheimer's Disease (Oral-1)

The Butler Hospital Memory & Aging Program is conducting a clinical research study of an orally-administered, investigational drug called scyllo-inositol(Oral-1).  This study tests whether the investigational drug Oral-1 safely provides clinical benefit to people with mild to moderate Alzheimer's disease (AD).

Qualified participants must be:

•  from 50 to 85 years of age
•  diagnosed with mild to moderate Alzheimer's disease
•  not taking Coumadin®
•  accompanied by a regular caregiver to 16 study visits over a 1.5-year period

For more information please call 401-455-6403.

All inquiries are confidential.